FDA Approved: EVRYSDI — Original Application (Genentech, Inc.)

View source ↗

Summary

FDA approved Evrysdi (risdiplam) in an Original Application, establishing it as an oral treatment option for spinal muscular atrophy. The approval provides a ne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Drugs mentioned

• EVRYSDI (risdiplam)

Snippet

ORIG AP for EVRYSDI (RISDIPLAM)